Johnson & Johnson vs. NewAmsterdam Pharma Company N.V. Ordinary Shares
JNJ
Johnson & Johnson
$281.27 -0.30%
VS NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares
$18.90 +0.05%
Johnson & Johnson and NewAmsterdam Pharma Company N.V. Ordinary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | NAMS | |
|---|---|---|
| Market Cap | $679.13 billion | $2.27 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | NAMS | |
|---|---|---|
| Dividend Yield | 1.91% | — |
JNJ and NAMS split the dividend factors evenly.
Risk & Sentiment
| JNJ | NAMS | |
|---|---|---|
| Short Interest | 0.67% | 0.01% |
NAMS leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, NAMS overview, NAMS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.